Unless there is a special indication, Blokium B12 is not used during pregnancy, especially during the last trimester of gestation, as diclofenac may inhibit uterine contractions and cause premature closure of the ductus arteriosus
Oral Administration (if applicable): For oral formulations of AOD-9604 , research has shown bioavailability of approximately 40% in animal studies
Metabolic Research Applications Beyond direct adipose effects, AOD 9604 has been studied for effects on metabolic parameters including glucose tolerance, insulin sensitivity, and energy expenditure
Follow your institution's safety procedures when handling research materials
Just clean technique and simple math
(2023) Phase 2 Retatrutide Trial, NEJM (PubMed) Coskun et al